Recent Finacing
Recent Raise
Glympse Bio develops bioengineered in vivo activity sensors that localize to disease sites and emit urine-detectable signals to noninvasively measure protease activity and monitor NASH, cancer, and infectious diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
